Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction

Carol Davila University of Medicine and Pharmacy

Status: Unknown

Conditions: Multiple Sclerosis

Treatments: Other: NO intervention

Study type: Observational

Funder types: Other

Identifiers

NCT03001284

UMFCD-141531-RM

Details and patient eligibility

About

Multiple sclerosis (MS), debilitating disease involving primarily the central nervous system, may cause cardiovascular dysfunction, due to autonomous nervous system dysfunction, physical invalidity, increased oxidative stress, and systemic inflammatory status, but the detailed mechanisms are not elucidated. The investigators aimed to assess left and right ventricular (LV and RV) function, left atrial (LA) function, arterial function, and atrial-ventricular-arterial coupling in patients with MS, compared to control subjects. LV systolic and diastolic function and RV function were assessed by 2D- and 3D- echocardiography, tissue Doppler, and speckle tracking echocardiography. LA function was assessed by LA volume index and LA strain. Arterial remodeling and stiffness were assessed by intima media-thickness, pulse wave velocity, and parameters of wave intensity and endothelial function

Enrollment: 103 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. age between 18 and 65 years;
2. patients with confirmed MS diagnosis, both newly diagnosed or already under immunomodulatory treatment;
3. informed consent signed.

Exclusion criteria

1. MS treated with mitoxantrone;
2. patients with known cardiovascular disease;
3. presence of other neurological conditions;
4. any renal, pulmonary, hepatic or hematological disease;
5. diabetes mellitus;
6. any degree of arterial hypertension;
7. pregnancy;
8. and difficult acoustic window

Trial design

103 participants in 2 patient groups

Multiple sclerosis patients

Description:

patients with confirmed multiple sclerosis, diagnosed according to the revised McDonald's criteria

Treatment:

Other: NO intervention

Control subjects

Description:

control subjects, matched for age, gender, and presence of cardiovascular risk factors

Treatment:

Other: NO intervention